Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Schizophrenia

Free Subscription 20.07.2026 1 J Clin Psychiatry 1 J Clin Psychopharmacol 1 J Nerv Ment Dis 1 Nat Genet 1 Neuropsychopharmacology 1 Pharmacopsychiatry 2 Psychiatry Res 4 Schizophr Res

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

J Clin Psychiatry

1. NAGAMINE T
   GLP-1 Receptor Agonists for Non-obese Asian Patients With Schizophrenia: Beyond the Body Mass Index Paradigm.
   J Clin Psychiatry. 2026;87:26lr16549.
   PubMed        
   
   

   
   J Clin Psychopharmacol

2. MARDER SR, Kelly DL, DeVera G, Zaranski JO, et al
   Withania somnifera (Ashwagandha) as an Adjunctive Treatment to Antipsychotic Medications for Patients With Schizophrenia.
   J Clin Psychopharmacol. 2026 Jul 17. doi: 10.1097/JCP.0000000000002229.
   PubMed         Abstract available
   
   

   
   J Nerv Ment Dis

3. SEJDIU A, Jaka S, Anusheel, Taneja S, et al
   Risk Factor Analysis for Schizophrenia Spectrum Disorder-related Hospitalization in Children, Adolescents, and Transitional-Age-Youth: Results From Nationwide Inpatient Study.
   J Nerv Ment Dis. 2026;214:54-58.
   PubMed         Abstract available
   
   

   
   Nat Genet

4. MARDERSTEIN AR, Kundu S, Padhi EM, Deshpande S, et al
   Decoding common and rare noncoding variant effects across cellular and developmental contexts.
   Nat Genet. 2026;58:1517-1529.
   PubMed         Abstract available
   
   

   
   Neuropsychopharmacology

5. KWON SH, Martinowich K
   Neuronal genetic risk within the multicellular landscape of schizophrenia.
   Neuropsychopharmacology. 2026 Jul 10. doi: 10.1038/s41386-026-02497.
   PubMed        
   
   

   
   Pharmacopsychiatry

6. DI FRANCESCO A, Munafo A, Catania G, Aprile SF, et al
   Efficacy and tolerability of nutraceuticals and phytotherapics for antipsychotic-induced weight gain in schizophrenia spectrum disorders: Systematic review and meta-analysis.
   Pharmacopsychiatry. 2026 Jul 13. doi: 10.1055/a-2869-0635.
   PubMed         Abstract available
   
   

   
   Psychiatry Res

7. ZHANG X, Li X, Zhang G, Li C, et al
   Association between serum uric acid levels and cognitive performance in first-episode drug-naive schizophrenia: A large cross-sectional study.
   Psychiatry Res. 2026;364:117314.
   PubMed         Abstract available
   
   
8. ZHANG Y, Liu Y, Wang X, Zhu Y, et al
   The impact of sleep and physical activity on the quality of life of community-dwelling Schizophrenia patients: a cross-sectional study.
   Psychiatry Res. 2026;364:117312.
   PubMed         Abstract available
   
   

   
   Schizophr Res

9. EYUBOGLU MS, Demirlek C, Demir M, Cesim E, et al
   A comprehensive investigation of social cognition across different stages of psychosis: A staging model comparison including familial high-risk, ultra high-risk, first episode and chronic patients.
   Schizophr Res. 2026;296:138-146.
   PubMed         Abstract available
   
   
10. SANDRONI V, Szoke A, Peyre H, Amoretti S, et al
    IQ and subclinical psychosis: The role of psychosocial stressors and core schemata.
    Schizophr Res. 2026;296:130-137.
    PubMed         Abstract available
    
    
11. MASHIMA Y, Shinagawa K, Suzuki H, Onaya M, et al
    Post-conclusion belief inflexibility bias assessed by a modified beads task in schizophrenia.
    Schizophr Res. 2026;296:121-129.
    PubMed         Abstract available
    
    
12. JUNG S, Lee DH, Hong M, Kim MK, et al
    Association of COVID-19 vaccination with improved treatment adherence in patients with schizophrenia: A propensity score-matched cohort study.
    Schizophr Res. 2026;296:111-120.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Schizophrenia is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum